Vaxxinity Inc (VAXX)

[PonkenPlonken]

i feel sorry for Mei Mei and the team. The timing of the IPO and the small cap biotech bearmarket hurt them badly. Wrong place wrong time.
Lets see, i dont think you can hold Mei Mei down.

[TrendTrade2016]

VAXX monster move

[TrendTrade2016]

Delist play

[TrendTrade2016]

VAXX blowing up

[glenn1919]

VAXX................................https://stockcharts.com/h-sc/ui?s=VAXX&p=W&b=5&g=0&id=p86431144783

[Renee]

VAXX delisted from the Nasdaq to the OTC:

https://otce.finra.org/otce/dailyList?viewType=Additions

[stock1ace1]

Why? Delisting ..

[Triple nickle]

Load em up

[Awl416]

No clue why

[Awl416]

Pop

[Tom turtles]

Lol...bye bye VAXX...good riddance

[Awl416]

Vaxxinity Announces Intention to Voluntarily Delist and Deregister its Class A Common Stock

[Awl416]

Vaxxinity Announces Positive Target Engagement Data from Phase 1 Clinical Trial for Parkinson’s Disease at AD/PD™ 2024

[81vette]

not off hand,look on fda site,let us know,thanks!!!

[Monroe1]

Any idea when the Phase 3 trial should finish?

[Monksdream]

VAXX new 52 week low

[Monksdream]

VAXX under $2

[Monksdream]

VAXX new 52 week low

[Monksdream]

VAXX new 52 week low

[Monksdream]

VAXX under $2

[81vette]

new and effective covid booster news coming is the thought,15 days of charting up and institutions loading while crickets are chirping

[81vette]

https://ih.advfn.com/stock-market/NASDAQ/vaxxinity-VAXX/stock-news/89692734/vaxxinity-announces-positive-topline-pivotal-phase

[81vette]

10Xs ave vol,blowing up scanners on this low float

[81vette]

1M short ,squeeze babe !!! could be big news enroute with institutional buying like this

[81vette]

biggest ever institution loading> Bank Of America 3.22 mm +3.20 mm +20179.3%
Vanguard 1.53 mm +1.48 mm +2676.7%
Marshall Wace 620.46 k +620.46 k NEW
Element Capital Management 376.89 k +376.89 k NEW
Creative Planning 277.52 k +277.52 k NEW
Renaissance Technologies 262.40 k +262.40 k NEW
Millennium Management 213.62 k +213.62 k NEW
Prime Movers Lab 17.85 mm -179.00 k -1.0%
Two Sigma Investments 128.52 k +128.52 k NEW
Ghisallo Capital Management 100.00 k +100.00 k NEW

[81vette]

3Xs ave vol.,no news,dbl bottom,47% insider owned

[bandit007]

Loaded the crap out of this today

[bandit007]

Sexy looking bottom chart. Starting to move up now. $VAXX

[bandit007]

Stop losses below 3 got taken out. Should start moving up now

[bandit007]

Took a few down here

[TheFinalCD]

and on low volume

[bandit007]

Got vaxx? :)

[bandit007]

Breaking out

[bandit007]

On watch again

[bandit007]

I only hold a small position speculating here. Could be either gold or fool’s gold. Could pay off well if it ends up being the real deal. GL

[Deano361]

Trading nicely today now and not spikey

[Deano361]

I'm in this one now. Can't figure out if real or not. Some guy on Twits board claims it's a Nancy Pelosi fraud lol! I have no idea but if they truly figure out a Alz vaccine this will be like Moderna in the 100s

[bandit007]

Nice bounce back from the morning dip. $VAXX

[bandit007]

VAXX hod close?

[crudeoil24]

Nice trade! Maybe some news coming next week.

[TheFinalCD]

5.74 vol HALT down

only P1 news

I learned from crude to be careful with P1's I got burned on one that I lost $80,000

#HardLesson

[Awl416]

Impressive

[TheFinalCD]

GOT VAXX?

[crudeoil24]

VAXX halted > Nasdaq circuit breaker.

[crudeoil24]

Vaxxinity Shares Surge More Than 40% in Trading Debut After IPO VAXX
12:02 pm ET November 11, 2021 (Dow Jones)

[crudeoil24]

Vaxxinity, Inc. is a biotechnology company. The Company’s synthetic peptide vaccine platform (Vaxxine Platform) enables a new class of therapeutics that will improve the access to treatments for a range of indications. Its Vaxxine Platform is designed to connect the immune system to convert the body into its own drug factory, stimulating the production of antibodies with a therapeutic or protective effect. Its technology uses synthetic peptides to mimic and optimally combine biological epitopes in order to selectively activate the immune system, producing antibodies against only the desired targets, including self-antigens, making possible the safe and effective treatment of chronic diseases by vaccines. The modular and synthetic nature of its Vaxxine Platform provides significant in candidate development and has generated multiple product candidates that it is designing for many chronic diseases.